Evobrutinib Initiation in Newly Enrolled MS Patients Has Been Partially Suspended by FDA.

Published Date: 16 Apr 2023

A highly selective BTK inhibitor called evobrutinib has previously shown to have favorable effects on relapse rates and neurofilament light in people with relapsing multiple sclerosis.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?

2.

DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance

3.

For patients with prostate cancer, long-term follow-up helps identify treatment side effects.

4.

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

5.

Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot